• News Releases

Genoa Telepsychiatry Launches With the Acquisition of 1DocWay

Nov 4th, 2015

Genoa is excited to announce it has recently acquired 1DocWay, the nation’s largest telepsychiatry provider that offers a simple, easy-to-use platform to connect behavioral healthcare providers and consumers. Genoa will provide this service to existing center partners or other behavioral health centers that need additional providers to serve their consumers. We will continue to serve the behavioral health community by providing on-site pharmacies to behavioral health facilities and are excited to bring this new offering to our partners. By collaborating with 1DocWay, a company that shares our vision to serve the behavioral health community, we will be able to leverage their expertise and capabilities to continue to build services to move us forward as a company and help enhance the level of care within the behavioral health community. For more details about this acquisition, see the links below or contact us at [email protected] or (866) 763-2250 today! Press Release 1DocWay

Recent Posts

  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...